Title:
ＣＸＣＲ７受容体調節剤
Document Type and Number:
Japanese Patent JP6582056
Kind Code:
B2
Abstract:
wherein (R1)n, ring (A), Y1, Y2, X, R4, L1, L2, and A1 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.
Inventors:
Philip Gerry
Francois le amble
Julian Potier
Hervegin
Francois le amble
Julian Potier
Hervegin
Application Number:
JP2017547075A
Publication Date:
September 25, 2019
Filing Date:
November 30, 2015
Export Citation:
Assignee:
IDORSIA PHARMACEUTICALS LTD
International Classes:
C07D267/14; A61K31/55; A61K31/5513; A61K31/553; A61P1/16; A61P11/00; A61P13/12; A61P19/04; A61P29/00; A61P35/00; A61P35/02; A61P37/06; A61P43/00; C07D223/16; C07D243/14; C07D413/12; C07D413/14; C07D417/12
Domestic Patent References:
| JP2002371042A | ||||
| JP2010507665A | ||||
| JP2011506569A | ||||
| JP6511239A | ||||
| JP2006515854A |
Foreign References:
| US20050192272 | ||||
| US20100210593 |
Attorney, Agent or Firm:
Mitsue Obuchi
Yukio Fuse
Yukio Fuse